-transparent.png){kind=logo}
Recent experimental evidence has suggested that the alpha 1 adrenoceptor may need to be further subdivided. It can no longer be stated categorically that alpha 1-adrenoceptors are present only at postjunctional sites, in view of several reports of alpha 1-mediated modulation of adrenergic and cholinergic neurotransmission. Furthermore, comparison of the pharmacologic characteristics of the alpha 1-adrenoceptor in different species and/or tissues can show clear differences in sensitivity to selective agonists and antagonists, and differences in the degree of dependence on extracellular calcium. However, in other cases, alpha 1-adrenoceptors at diverse sites have been found to have identical characteristics. Furthermore, the subcategories identified by the various selective agents do not fall into the same discrete groups, in contrast to division of alpha-adrenoceptors into alpha 1 and alpha 2-adrenoceptors. Therefore, at this time it seems premature to subdivide the alpha 1-adrenoceptor further.
J P Hieble, and
R M DeMarinis, and
W D Matthews
January 1991,
Pharmacology,
J P Hieble, and
R M DeMarinis, and
W D Matthews
January 1990,
Proceedings of the Western Pharmacology Society,
J P Hieble, and
R M DeMarinis, and
W D Matthews
October 1992,
Current eye research,
J P Hieble, and
R M DeMarinis, and
W D Matthews
October 1990,
British journal of pharmacology,
J P Hieble, and
R M DeMarinis, and
W D Matthews
January 1989,
Pharmacology & therapeutics,
J P Hieble, and
R M DeMarinis, and
W D Matthews
July 1992,
Biochemical and biophysical research communications,
J P Hieble, and
R M DeMarinis, and
W D Matthews
April 1988,
The American journal of physiology,
J P Hieble, and
R M DeMarinis, and
W D Matthews
January 1990,
Acta physiologica Hungarica,
J P Hieble, and
R M DeMarinis, and
W D Matthews
July 1986,
British journal of pharmacology,
J P Hieble, and
R M DeMarinis, and
W D Matthews
August 2006,
Fundamental & clinical pharmacology,
